{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:20:03Z","timestamp":1782260403041,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd011694","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000}}],"reference-count":86,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011694.pub2","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T13:21:46Z","timestamp":1468848106000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cannabinoids for fibromyalgia"],"prefix":"10.1002","volume":"2020","author":[{"given":"Brian","family":"Walitt","sequence":"additional","affiliation":[{"name":"National Institute of Nursing Research; National Institutes of Health; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Klose","sequence":"additional","affiliation":[{"name":"Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine; University of Duisburg-Essen; Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Fitzcharles","sequence":"additional","affiliation":[{"name":"Division of Rheumatology; Montreal General Hospital, McGill University Health Centre; Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Phillips","sequence":"additional","affiliation":[{"name":"Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy; Technische Universit\u00e4t M\u00fcnchen; M\u00fcnchen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"10.1002\/14651858.CD011694.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesthesia & Analgesia"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0003|cit3","unstructured":"Supporting effect of dronabinol on behavioral therapy in fibromyalgia and chronic back pain clinicaltrials.gov\/ct2\/show\/NCT00176163"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0004|cit4","unstructured":"Efficacy trial of oral tetrahydrocannabinol in patients with fibromyalgia clinicaltrials.gov\/ct2\/show\/NCT01149018"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0006|cit6","unstructured":"PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the Fibromyalgia Impact Questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"American Journal Medicine"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2011","journal-title":"Journal Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1517\/14656566.2014.918102","article-title":"Dronabinol and chronic pain: importance of mechanistic considerations","volume":"15","author":"Vries","year":"2014","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD011694.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome: general principles and coordination of clinical care and patient education [in German]","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving crossover trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research & Management"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.22267","article-title":"The dilemma of medical marijuana use by rheumatology patients","volume":"66","author":"Fitzcharles","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e18440","DOI":"10.1371\/journal.pone.0018440","article-title":"Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life","volume":"6","author":"Fiz","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0019|cit19","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self reported musculoskeletal pain","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"29","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0021|cit21","unstructured":"GRADEpro GDT 2015: GRADEpro Guideline Development Tool McMaster University 2015"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0023|cit23","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0025|cit25","first-page":"271","article-title":"Risks associated with the non-medical use of cannabis","volume":"112","author":"Hoch","year":"2015","journal-title":"Deutsches Arzteblatt International"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome - a somatoform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"H\u00e4user","year":"2014","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1155\/2001\/469629","article-title":"Medicinal use of cannabis: history and current status","volume":"6","author":"Kalant","year":"2001","journal-title":"Pain Research & Management"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review [in German]","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2012.09.017","article-title":"Amygdala activity contributes to the dissociative effect of cannabis on pain perception","volume":"154","author":"Lee","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0041|cit41","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD011694.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011694.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011694.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011694.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011694.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011694.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011694.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011694.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011694.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD011694.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011694.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011694.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.33346","article-title":"Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway","volume":"64","author":"Mork","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0059|cit59","unstructured":"National Pain Foundation Marijuana rated most effective for treating fibromyalgia, 2014 www.thenationalpainfoundation.org\/pain-news.php"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00005650-200110000-00002","article-title":"Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life","volume":"39","author":"Norman","year":"2001","journal-title":"Medical Care"},{"issue":"1","key":"10.1002\/14651858.CD011694.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/525S6a","article-title":"Drug development: the treasure chest","volume":"525","author":"Owens","year":"2015","journal-title":"Nature"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011694.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0066|cit66","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0067|cit67","first-page":"192","article-title":"Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"29","author":"Russo","year":"2008","journal-title":"Neuro Endocrinology Letters"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","article-title":"Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration [in German]","volume":"29","author":"Schaefert","year":"2015","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1185\/030079906X112651","article-title":"Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"27","author":"Schley","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome [in German]","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/acr.21732","article-title":"Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia","volume":"64","author":"Ste-Marie","year":"2012","journal-title":"Arthritis Care & Research (Hoboken)"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000078843","article-title":"Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together","volume":"73","author":"Van Houdenhove","year":"2004","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0075|cit75","first-page":"879","article-title":"Adverse health effects of marijuana use","volume":"371","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"pii: 827290","DOI":"10.1155\/2009\/827290","article-title":"Tetrahydrocannabinol (Delta 9-THC) treatment in chronic central neuropathic pain and fibromyalgia patients: results of a multicenter survey","volume":"2009","author":"Weber","year":"2009","journal-title":"Anesthesiology Research and Practice"},{"issue":"11","key":"10.1002\/14651858.CD011694.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD011694.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: cytokines in fibromyalgia syndrome","volume":"28","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011694.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1093\/brain\/awt115","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD011694.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011694.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:46:36Z","timestamp":1772765196000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011694.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011694.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}